Accession Number: | 0001104659-21-080833 |
Date: | 2021-06-10 |
Issuer: | Y-MABS THERAPEUTICS, INC. (YMAB) |
Original Submission Date: |
BER GERARD
C/O Y-MABS THERAPEUTICS, INC.
230 PARK AVENUE SUITE 3350
NEW YORK, NY 10169
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|---|---|---|---|---|---|---|---|---|---|---|---|
NON-EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 37.53 | 2021-06-10 | deemed execution date | A | 16,000 (a) | 2021-07-10 | 2031-06-10 | common stock 16,000 | $37.53 | 16,000 | direct |
ID | footnote |
---|---|
f1 | stock options granted to the reporting person as a non-employee director pursuant to the 2018 equity incentive plan of y-mabs therapeutics, inc. |
f2 | the stock options vest in equal monthly installments during the first year following the date of grant, subject to the reporting person's continued service on the board of directors of y-mabs therapeutics, inc., and are exercisable immediately upon vesting. |